Kavya Deshpande
Stock Analyst at UBS
(2.36)
# 3,093
Out of 5,108 analysts
56
Total ratings
60.7%
Success rate
2.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kavya Deshpande
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: SN Smith & Nephew plc | Reiterated: Hold | 1,210p | 1,162p | +4.18% | 1 | Nov 5, 2026 | |
| SWX: SOON Sonova Holding AG | Downgraded: Hold | CHF 273.00 → CHF 293.00 | CHF 284.60 | +2.95% | 5 | Nov 2, 2026 | |
| BIT: DIA DiaSorin S.p.A. | Reiterated: Sell | €66.00 → €55.00 | €79.76 | -31.04% | 18 | Aug 24, 2026 | |
| EPA: BIM bioMérieux S.A. | Reiterated: Hold | €80.00 → €78.00 | €92.80 | -15.95% | 14 | Jul 29, 2026 | |
| STO: VIMIAN Vimian Group AB (publ) | Reiterated: Hold | kr 30.00 → kr 35.00 | kr 41.95 | -16.57% | 17 | Jul 28, 2026 | |
| STO: EKTA.B Elekta AB (publ) | Initiated Coverage: Sell | kr 34.00 | kr 59.85 | n/a | 1 | Sep 3, 2025 |
Smith & Nephew plc
Nov 5, 2026
Reiterated: Hold
Price Target: 1,210p
Current: 1,162p
Upside: +4.18%
Sonova Holding AG
Nov 2, 2026
Downgraded: Hold
Price Target: CHF 273.00 → CHF 293.00
Current: CHF 284.60
Upside: +2.95%
DiaSorin S.p.A.
Aug 24, 2026
Reiterated: Sell
Price Target: €66.00 → €55.00
Current: €79.76
Upside: -31.04%
bioMérieux S.A.
Jul 29, 2026
Reiterated: Hold
Price Target: €80.00 → €78.00
Current: €92.80
Upside: -15.95%
Vimian Group AB (publ)
Jul 28, 2026
Reiterated: Hold
Price Target: kr 30.00 → kr 35.00
Current: kr 41.95
Upside: -16.57%
Elekta AB (publ)
Sep 3, 2025
Initiated Coverage: Sell
Price Target: kr 34.00
Current: kr 59.85
Upside: n/a